Bolar provisions in India's patent law


In May 2003, when India's Patent Act was amended, a new Section 107A was introduced. This provided for a research exemption as an exception to the general rules of patent infringement. Commonly known as a Bolar provision, this research exemption enables a manufacturer of generic drugs to use a patented invention to obtain marketing approval without the patent owner's permission before the patent expires. The generic drug maker...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @The_IPO: Opening of the #UKChina IP symposium which began today http://t.co/rXGlBMypCo http://t.co/dEEsplCcNJ

Sep 1 2014 09:21 ·  reply ·  retweet ·  favourite
ManagingIP profile

Berne Convention to be extended to Guernsey; enters into force on November 21 2014 http://t.co/laG7rIuaUh @WIPO

Sep 1 2014 09:04 ·  reply ·  retweet ·  favourite
ManagingIP profile

China's National People's Congress announces establishment of IP courts in Beijing, Shanghai and Guangzhou http://t.co/eXcF0ggvSe

Sep 1 2014 04:27 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


September 2014

The surprising rise of the PTAB

Patent owners have been shocked at how popular IPR proceedings at the PTAB have proven. As the USPTO mulls over changes and the Federal Circuit braces itself for a deluge of appeals, Michael Loney reports on how the PTAB is likely to evolve



Most read articles

Supplements